Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ken Kawabe

Showing results (51-60 of 59) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 59 results.
Cancer Medicine|October 25, 2020
nal-IRI+5-FU/LV versus 5-FU/LV in post-gemcitabine metastatic pancreatic cancer: Randomized phase 2 trial in Japanese patientsMakoto Ueno, Shoji Nakamori, Kazuya Sugimori, et al.
Journal of Gastroenterology|August 3, 2007
Preliminary results of a Japanese nationwide survey of neuroendocrine gastrointestinal tumorsTetsuhide Ito, Masao Tanaka, Hironobu Sasano, et al.
World Journal of Gastroenterology|March 26, 2015
Hepcidin/ferroportin expression levels involve efficacy of pegylated-interferon plus ribavirin in hepatitis C virus-infected liverMotoyuki Kohjima, Tsuyoshi Yoshimoto, Munechika Enjoji, et al.
World Journal of Gastroenterology|February 9, 2016
Diagnostic and therapeutic single-operator cholangiopancreatoscopy in biliopancreatic diseases: Prospective multicenter study in JapanToshio Kurihara, Ichiro Yasuda, Hiroyuki Isayama, et al.
World Journal of Gastroenterology|March 2, 2017
Familial pancreatic cancer: Concept, management and issuesHiroyuki Matsubayashi, Kyoichi Takaori, Chigusa Morizane, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|August 27, 2024
Prospective multicenter surveillance study of branch-duct intraductal papillary mucinous neoplasm of the pancreas; risk of dual carcinogenesisTakao Ohtsuka, Hiroyuki Maguchi, Shoji Tokunaga, et al.
The Oncologist|August 10, 2022
Comparing the Efficacy and Safety of Gemcitabine plus Nab-Paclitaxel versus Gemcitabine Alone in Older Adults with Unresectable Pancreatic CancerSatoshi Kobayashi, Motoko Suzuki, Makoto Ueno, et al.
Journal of Gastroenterology|April 26, 2023
Machine learning-based model for prediction and feature analysis of recurrence in pancreatic neuroendocrine tumors G1/G2Masatoshi Murakami, Nao Fujimori, Kohei Nakata, et al.
Immunological Medicine|November 28, 2024
Clinical profile of IgG4-related disease in Japan based on the rare disease data registryMotohisa Yamamoto, Masatoshi Kanda, Ichiro Mizushima, et al.
Pageof 6

Showing results (51-60 of 59) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
Cancer Medicine|October 25, 2020
nal-IRI+5-FU/LV versus 5-FU/LV in post-gemcitabine metastatic pancreatic cancer: Randomized phase 2 trial in Japanese patientsMakoto Ueno, Shoji Nakamori, Kazuya Sugimori, et al.
Journal of Gastroenterology|August 3, 2007
Preliminary results of a Japanese nationwide survey of neuroendocrine gastrointestinal tumorsTetsuhide Ito, Masao Tanaka, Hironobu Sasano, et al.
World Journal of Gastroenterology|March 26, 2015
Hepcidin/ferroportin expression levels involve efficacy of pegylated-interferon plus ribavirin in hepatitis C virus-infected liverMotoyuki Kohjima, Tsuyoshi Yoshimoto, Munechika Enjoji, et al.
World Journal of Gastroenterology|February 9, 2016
Diagnostic and therapeutic single-operator cholangiopancreatoscopy in biliopancreatic diseases: Prospective multicenter study in JapanToshio Kurihara, Ichiro Yasuda, Hiroyuki Isayama, et al.
World Journal of Gastroenterology|March 2, 2017
Familial pancreatic cancer: Concept, management and issuesHiroyuki Matsubayashi, Kyoichi Takaori, Chigusa Morizane, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|August 27, 2024
Prospective multicenter surveillance study of branch-duct intraductal papillary mucinous neoplasm of the pancreas; risk of dual carcinogenesisTakao Ohtsuka, Hiroyuki Maguchi, Shoji Tokunaga, et al.
The Oncologist|August 10, 2022
Comparing the Efficacy and Safety of Gemcitabine plus Nab-Paclitaxel versus Gemcitabine Alone in Older Adults with Unresectable Pancreatic CancerSatoshi Kobayashi, Motoko Suzuki, Makoto Ueno, et al.
Journal of Gastroenterology|April 26, 2023
Machine learning-based model for prediction and feature analysis of recurrence in pancreatic neuroendocrine tumors G1/G2Masatoshi Murakami, Nao Fujimori, Kohei Nakata, et al.
Immunological Medicine|November 28, 2024
Clinical profile of IgG4-related disease in Japan based on the rare disease data registryMotohisa Yamamoto, Masatoshi Kanda, Ichiro Mizushima, et al.
Pageof 6